Sickle cell anaemia
Sickle cell anaemia (SCA) is a serious genetic haemoglobinopathy caused by a beta globin gene mutation expressing haemoglobin S. The disease is very frequent in Africa, and among African descendants in Europe, North and South America, but it also exists around the Mediterranean, in the Middle East and in Asia. In developed countries, survival is no longer a major problem, due to early detection of the disease and high standards of care. Nevertheless, morbidity remains high with a stroke risk, in the absence of intervention, of 11% before the age of 18 years [16]. Most strokes are due to a macro-angiopathy affecting the terminal internal carotid arteries and proximal middle and anterior cerebral arteries, with smooth muscle hyperplasia and intimal fibrosis that lead to progressive stenosis and occlusion with moyamoya-like collateral development [17]. Chronic transfusions are effective in reducing the risk of (1) recurrent ischaemic stroke, and (2) a first stroke in children with HbSS who have abnormally high velocities on TCD [18].
TCD has become an essential tool in the management of SCA, recommended by the French Authority of Health and by the United States Department of Health and Human Services (type A, class I evidence) [1, 19, 20]. In children who have suffered a stroke, it detects arteriopathy with a sensitivity of 90% and specificity of 100% compared to cerebral angiography [21]. The most important application is in evaluation of stroke risk in neurologically asymptomatic SCA patients. In the 1990s, Adams et al. [22] demonstrated that an abnormal TCD is linked to high risk of a first stroke, and that chronic transfusions reduce this risk. One hundred ninety children were screened with TCD and followed for an average of 29 months; 23 had a TAMX >170 cm/s; strokes occurred in seven patients, including six among the 23 patients with abnormal TCD. This result was confirmed by a subsequent study [23] including 125 more children, which showed that a TAMX ≥200 cm/s in the terminal ICA, or in the MCA, indicates a 10% risk for stroke per year, compared to a 2% risk in patients with normal TCD.
In the randomised multi-centre North American STOP I-study (stroke prevention trial in sickle cell anaemia) [18], 1,934 HbSS or HbSB0 children from 2 to 16 years old were screened with TCD. Children with TAMX ≥200 cm/s in the MCA or ICA were randomised into two groups. Sixty-three children received periodic blood transfusions or exchange transfusions designed to maintain their haemoglobin S level ≤30%. Sixty-seven children received standard supportive care with symptomatic treatment. After a year, ten children in the standard care group had a stroke, while only one child in the transfusion group had a stroke, indicating a 92% relative reduction in stroke rate (P < 0.001). Subsequently, the National Institute of Health in the United States issued an alert recommending TCD-screening in children 2–16 years old with SCA, and long-term transfusion treatment in children with an abnormal TCD.
The efficiency of this stroke prevention protocol was later confirmed by several studies. Fullerton [24] observed a 5-fold decrease in the rate of first stroke in Californian children with sickle cell disease within 2 years following the implementation of the STOP-based protocol. In Memphis, the stroke rate decreased from 0.46 to 0.18 per 100 person-years after the TCD screening rate reached 99% [25]. In a newborn SCA-cohort of Creteil, France, including 217 SS/Sβ0 thalassaemia patients, early and annually screened with TCD since 1992, the cumulative stroke risk by age 18 was 1.9% (95% CI, 0.6–5.9) [14, 26, 27]. In Philadelphia, the incidence of overt stroke in the post-TCD period was 0.06 per 100 patient-years, compared with 0.67 per 100 patient-years in the pre-TCD period [28].
According to the French and U.S. guidelines [19, 20], children with SCA should be screened with TCD from the second year of life and then re-scanned annually until 16 years old if normal (i.e. highest TAMX of any artery <170 cm/s), quarterly if conditional (TAMX of at least one artery 170–199 cm/s), and regular transfusions should be initiated in case of abnormal TCD (TAMX in at least one artery ≥200 cm/s) (Table 2; Fig. 4). Correlation with magnetic resonance angiography (MRA) is useful in children with abnormal or inadequate TCD, e.g. where there is no useful acoustic window. It is worth noting that abnormal velocity does not equal angiographic stenosis. TCD is a more sensitive technique, and it detects arterial disease at an earlier stage than MRA. But children with abnormal TCD and abnormal MRA are at higher risk for stroke than those with an abnormal TCD alone [29] (Fig. 5).
In STOP-I [18], the diagnostic distribution at initial TCD examinations was: 67% normal, 17.6% conditional, 9.3% abnormal, and 6% inadequate. In a French cohort [14], TCD was abnormal in 21% of SCA-patients at a median age of 3.2 years (range, 1.3–8.3). In 44% of these, conditionally abnormal TCD had been observed earlier. The cumulative risk of abnormal TCD by age 14 in SS/SB0 patients was 29.6% (95% CI, 22.8–38.0%), with a plateau starting at age 9 years.
Conditional velocities are more likely to become abnormal when the child is younger and when velocities are close to 200 cm/s [14, 30]. In the French cohort, conditional TCD occurred in 58/217 patients and became abnormal in 20/58 patients (34.5% conversion rate). The median age of conditional TCD was 2.5 years (range, 1.2–5.5) and the median delay 1.1 years (range, 0.03–7). Age less than 4 years was a significant risk factor for conversion (OR = 6.7; 95% CI, 1.7–27). In the STOP study, the conversion risk was 97% in very young children with two consecutive conditional TCD examinations, and 13% in teenagers seen for the first time at the age of 14 years [31].
Since the objective of the examination is to detect focal acceleration of blood flow, it is important to carefully explore the entire arteries by sweeping the sample gate along the MCA and the ICA during spectral recording, and optimising the pulsed spectrum at each depth by slightly tilting the probe in order to get the highest velocity. Expert operators trust the sound signal: the higher the pitch, the higher the velocity.
Monitoring cerebral haemodynamics in intensive care patients, particularly following traumatic brain injury
Traumatic brain injury (TBI) is an important factor in children's morbidity and mortality. Several important disturbances of cerebral haemodynamics follow TBI, including hyperaemia, cerebral ischaemia and vasospasm, which vary between patients, and from day to day in any individual. TCD, in association with other tools available for monitoring cerebral haemodynamics, may help in understanding the pathophysiology and guide management. Among the different cerebral arteries available for evaluation, the MCA is easiest to locate, and it provides the most reproducible data. Moreover, it supplies the largest part of the hemispheres.
High cerebral blood flow is a main cause of diffuse cerebral swelling leading to increased intracranial pressure and poor outcome. Hyperaemia can occur a few hours after TBI, last two to four days, and be followed by Doppler patterns suggestive of high vascular resistance, consistent with elevated intracranial pressure [32, 33]. Hyperaemia has also been reported in the first hours following an ischaemic event, particularly in neonates and children [34]. In adults, it has been well described as cerebral hyperperfusion syndrome following carotid endarterectomy or carotid artery stenting. This can provoke intracerebral haemorrhage and is believed to be caused by loss of autoregulation. It has also been reported in children with diabetic ketoacidosis and cerebral oedema, and is seen on TCD as increased flow velocities (twice normal values), and decreased PI and RI [35–37] (Fig. 6).
Cerebral ischaemia is the main cause of secondary deterioration in patients following TBI. Because of its non-invasiveness and ease in use, TCD may be an ideal tool for detecting decreased CBF and for evaluating the course of treatment [38, 39]. An initial TAMX <28 cm/s corresponds to an 80% likelihood of early death [40]. For Goutorbe et al. [41], a diastolic velocity <20 cm/s is predictive of poor outcome. In a prospective paediatric study including 36 children with moderate or severe TBI, diastolic velocity <25 cm/s and PI >1.31 on TCD at admission but after the first resuscitation phase (correction of low blood pressure, anaemia, hypoxia, hypoventilation), was associated with poor prognosis [42] (Fig. 7). TCD may also be used to monitor treatment. For example [43], vasopressors used for increasing mean arterial pressure and/or decreasing intracranial pressure will decrease PI and increase diastolic velocity and TAMX. Thus, the target mean arterial pressure can be estimated by TCD. Mannitol increases CBF and hence flow velocities.
Most recent studies have stressed the role of impaired CBF autoregulation in the poor outcome of patients after TBI, and the need for evaluating autoregulation. In children, impaired autoregulation has been reported in about 40% after TBI [44]. However, the adequacy of the autoregulation varies with time after injury, and may even differ between the hemispheres; therefore, single measurements may not reflect the true state [45, 46].
Intracranial vasospasm is a classic complication to aneurysmal subarachnoid haemorrhage or TBI. Vasospasm typically occurs 48 hours after subarachnoid haemorrhage and may last for 12–16 days. In adults, TCD has been proved useful for the detection and monitoring of vasospasm in the basal segments of the intracranial arteries, especially the MCA and basilar artery, following subarachnoid haemorrhage (Type A, Class I-II evidence) [1]. With a TAMX >120 cm/s as cut-off, sensitivity is good (92%), but specificity very low (50%). In clinical practice, vasospasm is highly suspected when TAMX >200 cm/s. The Lindegaard ratio, also called Aaslid ratio (the ratio of peak systolic velocities between MCA or anterior cerebral artery, and the ipsilateral extracranial ICA), may help differentiate high velocities due to generalised hyperaemia from vasospasm [3, 4]. A Lindegaard ratio of 3–6 is considered a sign of mild spasm, and >6 a sign of severe spasm. A rapid increase of MCA velocity of 50–65 cm/s over a period <24 h, rather than an absolute value, is predictive of poor prognosis and ischaemic deficit. Only arteriography is universally accepted as a confirmatory test. Nevertheless, MRA or CT angiography is often used due to their accessibility and shorter examination times.
Vasospasm is uncommon in children following TBI [47, 48]. In a study evaluating changes in cerebral haemodynamics after head injury, Mandera et al. [48] did not diagnose vasospasm in any patient. In a study comparing the TCD pulsatility index and intracranial pressure in children with traumatic brain injury, Figaji et al. [49] reported an 11% incidence of vasospasm. In a series of 22 children aged 7 months to 14 years, with moderate to severe traumatic brain injury as indicated by a Glasgow coma score <12 and abnormality on brain imaging, 36.3% had, on day 3–5, a flow velocity in the MCA >120 cm/s and a Lindegaard ratio >3, indicative of mild to moderate vasospasm when applying the criteria used in adults [50].
Brain death
Brain death denotes the complete and irreversible cessation of brain function due to a total arrest of cerebral blood flow. Diagnosis of brain death rests both on clinical criteria and confirmatory tests. In recent years, TCD has shown high sensitivity and specificity for determination of brain death in adults and children [51–54]. The proximal part of both MCA, and the basilar artery, are monitored at intervals. If the temporal window is not available, an orbital window can be used for the assessment of the carotid siphons. As cerebral oedema develops, cerebral perfusion pressure decreases, depicted by decreased diastolic velocities with no change of the systolic velocities, and raised RI and PI. When intracranial pressure is about the same as mean arterial pressure, diastolic flow velocity is zero with only high spiky systolic segments. This state may be reversible, if adequate treatment is possible. With a further fall in cerebral perfusion pressure to below mean arterial pressure, two patterns of flow can be recorded. (1) The “reverberating” or “oscillating” pattern of flow with short antegrade systolic, and reversed diastolic flow. The retrograde diastolic flow lasts longer, resulting in no net flow. (2) The “systolic spikes” with early antegrade systolic slow flow (<40–50 cm/s) of duration <200 ms, without diastolic flow, TAMX <10 cm/s. To be reliable, the abnormalities must be bilateral and unchanged over a 30-minute period. These two patterns are highly predictive of brain death (Type A, Class II evidence according to the American Academy of Neurology). Comparison with conventional arteriography has shown a 95% sensibility and 99% specificity [52]. In most countries, TCD is not used for confirming brain death, but it allows optimal timing of the formal confirmatory examination. There are a few pitfalls in the use of TCD in brain death, particularly in infants. Absent or retrograde diastolic flow can be found in children with systemic-to-pulmonary shunts, patent ductus arteriosus or aortic valve insufficiency [55]. Conversely, cerebrospinal fluid deviation, e.g. decompressive craniotomy, leading to a decreased intracranial vascular resistance, can cause persistence of normal flow patterns despite brain death. There can be a discrepancy between an abnormal MCA flow pattern and a non-conclusive basilar artery flow pattern. In this case, it is necessary to repeat the examination a few hours later and to perform the confirmatory examination only when the basilar artery flow becomes abnormal. In some cases, arrest of intracranial circulation may not occur at the same time in different arteries, and TCD waveforms can be different between the two MCAs, with more abnormal flow pattern on the more severely injured side, which emphasises the requirement for bilateral recording.
If no cerebral flow can be detected, technical problems, such as a poor acoustic window or non-optimal settings, must be excluded. The detection of a concomitant reversal of diastolic flow in the extracranial internal carotid artery could be a reliable sign of brain death [54].
Evaluation of the cerebral vasculature in stroke
Arteriopathies are the most common cause of arterial ischaemic stroke in children. The spectrum differs from that in adults and includes moyamoya, vasculitis, dissection, and transient cerebral arteriopathy (TCA). TCA, first recognised as an important cause of childhood stroke in 1998 [56], is characterised by lenticulo-striate infarction due to non-progressive unilateral arterial disease affecting the supraclinoid internal carotid artery and its proximal branches. The course of the disease is characterised by the stabilisation, improvement or even normalisation of the arterial lesions, sometimes after initial worsening during the first months. TCA is considered to a post infectious process, usually occurring in the 12 months after a Varicella zoster infection, but lately it has also been reported in association with other infectious agents, such as enterovirus, Borrelia burgdorferi, HIV, and West Nile virus [57]. TCA should be differentiated from moyamoya disease, which is a progressive arteriopathy affecting both carotid arteries (poorer prognosis), but which can be unilateral at presentation [58, 59]. TCD can make the evaluation of the arterial lesions in association with MRI and may be valuable in the follow-up of these patients, reducing the need for repeated MRI [60].
Others indications
TCD has also been used in children in the detection of intracranial arteriopathies in genetic disease (neurofibromatosis type 1, Williams syndrome) (Fig. 8) [61] and in internal carotid artery dissection [62].
TCD has been tried in non-specific headache or orthostatic dysregulation [63] and in hydrocephalus, without conclusive results. By comparing TCD parameters of 12 children with hydrocephalus before and after cerebrospinal fluid drainage to 13 children with essential ventriculomegaly and ten control children, Galarza and Lazareff [64] demonstrated slightly lower velocities, and higher RI and PI, in the hydrocephalus group, although all parameters remained within normal range, making TCD inadequate in clinical practice.
In adulthood, TCD has in some cases been reported to depict large arteriovenous malformations as serpiginous structures, and to identify feeder vessels with elevated velocities and decreased PI and RI. However, the sensitivity is very low compared to MRI and CT. TCD may be used as a supplementary test, in particular for monitoring the effects of surgical or vascular intervention. TCD is also used as part of multimodality neurological monitoring during surgery for congenital heart disease, allowing the evaluation of cerebral blood flow variations as well as the presence of emboli during, before and after cardiopulmonary bypass [65].